Myelin VC

myelin.vc

VCMatch tracks Myelin VC as an investor focused on Biotech, Medtech, and Digital Health companies, Seed and Series A rounds, and Latin America, Spain, and United States markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Biotech, Medtech, Digital Health

Geography

Latin America, Spain, and United States

Investment Thesis

Myelin is a founder-turned-investor firm that partners with exceptional founders to build transformative companies. Their approach emphasizes backing ‘outliers’ with visionary ideas and a deep commitment to investing in founders whose work aligns with a future the partners themselves want to live in. This suggests a values-driven, founder-centric investment philosophy grounded in the team’s own entrepreneurial experience.

Is Myelin VC right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Myelin VC is most relevant for founders raising Seed and Series A rounds in Biotech, Medtech, Digital Health, and Healthtech, especially across Latin America, Spain, and United States.

Focus statement

Myelin invests in founders with 'electrifying ideas' across all industries (industry agnostic) from seed through Series A. They specifically seek out founders building solutions addressing significant problems across healthcare, deep tech, fintech, food/consumer, and emerging technologies.

Value Add

Founders-turned-investors: The team has direct operational experience ('Been there, done that')
Industry agnostic approach: No sector restrictions, enabling broad opportunity identification
Values-aligned investing: Focus on ideas for 'a future we'd like to live in' suggests mission-driven selection
Stage flexibility: Invest from seed through Series A, providing continuity
Diverse portfolio: Portfolio spans biotech (Aura, Vitara), AI/software (Braid, Inkeep), fintech (Buenbit, Pomelo), space tech (Skyloom, Outpost), and consumer innovation